ImmuCell Corporation announced a net income of $953,000 for Q3 2026, marking a $1.1 million improvement from the same quarter in 2025. Revenue grew 46% to $8 million, driven by increased sales activity and distributor volume growth. The company is expanding manufacturing capacity and secured a new $3 million credit line, positioning itself for future demand. ImmuCell's strong financial performance reflects successful commercial efforts and operational investments in the animal health biologics market.
ImmuCell's Q3 2026 financial results provide context for readers following health-related companies. For readers following health-sector stocks, here is Pluang's market snapshot as of Nov 13, 2026 04:11 WIB: out of 150 priced US health-sector stocks, 23 rose and 124 fell today. Notable movers include BFLY at USD 6.64 with a -7.00% change, RXRX at USD 3.34 with a -6.96% change and a balanced 50% sell/buy order activity, and HRTX at USD 0.33 with a -6.90% change and 52% sell order activity.
Siemens reported earnings per share of $1.62 and revenue of $26.28 billion, both exceeding analyst expectations. The company saw record orders and double-digit revenue growth in its smart infrastructure and digital industries units, prompting it to r...
ASUS has introduced a broad ecosystem of AI-ready hardware and software designed for gamers, creators, developers, and enterprises. The ASUS Agent Computer initiative enables users to deploy AI locally, in the cloud, or via hybrid models, offering co...
The global cosmetic peptide synthesis market is projected to grow from $274 million in 2027 to $354.85 million by 2032, with a CAGR of 5.34%. Growth is fueled by rising demand for advanced anti-aging skincare ingredients, increased use of peptide-bas...
Cisco is set to report its fiscal Q1 2027 earnings with a focus on cloud growth and AI demand. Analysts expect revenue around $18.1 billion, operating income of $6.5 billion, and earnings per share of $1.33, reflecting strong year-over-year growth. T...
BASF has agreed to sell its global mining solutions business to SNF, a specialty chemical company based in France, following a strategic review of BASF's Performance Chemicals division. The deal includes BASF's mining chemicals portfolio, production ...
